论文部分内容阅读
作者最近治疗膀胱癌40例,男35例,女5例,年龄平均69.6(42—68),用阿糖胞甙(cytosine arabinoside,CA)和新制癌菌素(neocarzinostatin,NCS)联合注入膀胱内治疗。CA200mg+NCS4000u溶于30ml生理盐水,每2周灌注一次,10次为一疗程。结束后一周膀胱镜复查。无效者作手术治疗。若以此作术后辅助化疗预防复发,则以每周一次连续10次为一疗程。结果,发现CA、NCS联合灌注对膀胱癌有显明效果。经评定:肿瘤全消者7例,瘤体缩小或部分消失者15例,保持不变6例。术后22例作预防复发效
The author recently treated 40 cases of bladder cancer, including 35 males and 5 females, with an average age of 69.6 (42-68). They were injected into the bladder with a combination of cytosine arabinoside (CA) and neocarzinostatin (NCS). treatment. CA200mg+NCS4000u was dissolved in 30ml normal saline and was given every 2 weeks for 10 cycles. One week after the end of the cystoscopy. Invalid for surgical treatment. If this is used as a postoperative adjuvant chemotherapy to prevent recurrence, it will be treated once a week for 10 consecutive times. As a result, it was found that CA and NCS combined perfusion have a clear effect on bladder cancer. After evaluation, there were 7 cases of total tumor elimination, 15 cases of tumor shrinkage or partial disappearance, and 6 cases of unchanged tumors. 22 cases of postoperative recurrence